Healthcare

Racura Oncology has held investors' attention, with the market looking for the next catalyst to set direction. Racura Oncology has drawn attention from investors who follow emerging life-sciences names, with interest building around the cancer-focused end of the market where specialist backers tend to …

Consumer healthcare has become one of the fastest-evolving segments of the broader healthcare industry. As consumers increasingly focus on wellness, preventative health and convenient healthcare products, companies operating in this space continue searching for opportunities to expand their brands and distribution networks. That appears …

CSL Limited (ASX:CSL) is navigating a period of financial recalibration marked by revised guidance, asset impairments, and evolving segment dynamics across its global plasma and specialty medicines portfolio. The company’s latest disclosures, combined with market performance trends, reflect a transition phase where operational execution …

The ASX healthcare sector recorded a strong upward move in the latest session, with investors rotating into defensive growth names following improved risk appetite across globalEquitymarkets. The sector-wide rally was reflected in gains across major healthcare constituents, including CSL Ltd (ASX:CSL), ResMed CDI (ASX:RMD), …

ResMed Inc. (ASX:RMD) traded at 27.44 AUD, rising 3.53% in the latest session, outperforming the broader healthcare sector as represented by the S&P/ASX 200 Health Careindex, which gained 3.0% during the same period.

Telix Pharmaceuticals Limited (ASX:TLX) traded at 13.48 AUD, rising 4.58% in the latest session, outperforming broader healthcare sector movements as represented by the S&P/ASX 200 Health Careindex, which also posted gains of 3.0% during the same period.

In biotechnology, investors often focus on companies developing new medicines, but many healthcare innovations occur behind the scenes. Drug delivery technologies, which help improve how medicines are absorbed and administered, have become an increasingly important area of pharmaceutical development. That trend appears to be …